Učitavanje...

Cost-Effectiveness of HPV Vaccination and Cervical Cancer Screening in Women over Age 30 in the United States

BACKGROUND: Women over the age of 30 are the main beneficiaries of improved cervical cancer screening with human papillomavirus (HPV) DNA testing. The role of vaccination against HPV types 16 and 18, recommended routinely in pre-adolescent girls, is unclear in this age group. OBJECTIVE: To assess th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kim, Jane J., Ortendahl, Jesse, Goldie, Sue J.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779121/
https://ncbi.nlm.nih.gov/pubmed/19841455
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!